Analyst Ratings for ResMed (RMD) [Buys]
RMD Rating Summary
RMD Price Target Summary
- Highest: $227.00 (KeyBanc)
- Lowest: $158.00 (Jefferies)
- Average: $201.18
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$201.18 (+12.5%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 62%
Rating Score: 5.7 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/6/2024 | KeyBanc | Brett Fishbin | New Coverage | Overweight (N/A) |
227.00 (N/A) |
191.86 (178.85) |
-6.78% | Details |
| 10/27/2023 | Morgan Stanley » Updated 1/25/2024 |
Sean Laaman | Upgrade | Overweight (Equalweight) |
207.00 (186.00) |
138.73 (178.85) |
28.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
